Exploring the therapeutic potential of GLP-1 receptor agonists in the management of obstructive sleep apnea: a comprehensive review
The most frequently reported adverse events are GI manifestations such as nausea (15%), diarrhea (10%), and vomiting (7%) [2, 12,13,14]
BPC-157 has been investigated for interactions with VEGFR2-, FAK-, and eNOS-associated signaling pathways together with regulatory processes involving extracellular protein networks
The most frequent reason for discontinuing semaglutide and dulaglutide treatment was due to gastrointestinal disorders
Rot treatment also led to decreased mitochondrial respiration, reduced ATP and superoxide production, altered expression of mitochondrial dynamics proteins, diminished neuronal outgrowth and dendritic spine number and length, and impaired synaptic vesicle production and synapse formation
Enzyme gatekeepers